LQDA vs OGN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Liquidia Corporation presents a high-risk, high-reward profile characterized by a critical Piotroski F-Score of 1/9, indicating severe fundamental weakness. While the company has achieved explosive revenue growth (3054.60% YoY) and maintains a strong gross margin of 91.64%, its balance sheet is distressed with a Debt/Equity ratio of 4.42 and an ROE of -111.05%. The market is pricing in significant future success, as evidenced by a Price/Book ratio of 75.73, though insider selling and a bearish technical trend suggest a potential near-term peak. The disconnect between analyst optimism (Buy rating) and deterministic health scores necessitates a neutral stance.
OGN presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) and a critical Debt/Equity ratio of 11.70. While the stock has experienced a massive speculative rally over the last 60 days, the current price of $13.25 is significantly decoupled from its Graham Number ($7.82) and Intrinsic Value ($6.58). Fundamental deterioration is evident in the -5.30% revenue growth and -30.4% YoY EPS growth, suggesting the recent price surge is not supported by operational performance.
Compare Another Pair
Related Comparisons
LQDA vs OGN: Head-to-Head Comparison
This page compares Liquidia Corporation (LQDA) and Organon & Co. (OGN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.